From Glycemic Control to Weight-Centered Therapy: A Paradigm Shift in Type 2 Diabetes and Its Public Health Promise

Date

Authors

dc.identifier.issn

1661-8556
1661-8564

dc.identifier.doi

10.3389/ijph.2026.1608891

dc.description.volume

71

Publisher

FRONTIERS MEDIA SA

DOI

10.3389/ijph.2026.1608891
10.3389/ijph.2026.1608891

Keywords

diabesity , diabetes mellitus , liraglutide , obesity , semaglutide , Public, Environmental & Occupational Health

URI

https://doi.org/10.3389/ijph.2026.1608891
https://openaccess.acibadem.edu.tr/handle/11443/11324

Collections